Insider Cluster (2 insiders) ·Filed Jul 22, 2026

UTHR

UNITED THERAPEUTICS Corp
NEUTRAL
Impact 2/10
Horizonimmediate Processed2mo ago
Insider cluster: 2 insiders, $521K total
Actionable Insight • Neutral

The dollar amounts are too small to convey a directional signal. Watch for any acceleration in CEO selling volume or a shift to larger open-market sales without option exercises, which would warrant closer attention. For now, this cluster is routine.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d ⚠ clustered
UTHR ▲ +0.03% at T+20d
NEUTRAL call ✓ call won +0.03% · α vs SPY -2.87% · entry $527.07 → $527.21
Next anchor: T+60d in 12d
Latest observation: T+48 -2.33% FF3 residual α
Entry anchored
Jul 21, 03:59 PM ET
via exchange tick
T+1d
+0.47%
call +0.47% · α +1.70%
$529.53
settled 2mo ago
T+5d
-0.45%
call -0.45% · α +1.95%
$524.70
settled 2mo ago
T+20d
+0.03%
call +0.03% · α -2.87%
$527.21
settled 6w ago
T+60d
—
call — · α —
—
in 12d

Price Chart

Loading chart...

Executive Summary

A minor insider selling cluster at UTHR — CEO Rothblatt and EVP/GC Mahon sold a combined $521K in open-market transactions over the past week. Relative to UTHR's $22.7B market cap, the total is trivial (0.0023%), and the CEO's larger sales in the same period (from separate filings) fall below materiality thresholds. No bearish signal from the cluster alone.

Key Financial Metrics

Direction
selling
Total Value
$521.0K
Insiders
2

Key Facts

  • CEO Rothblatt sold 120 shares at $524.37 for $63K on 2026-07-21
  • EVP & General Counsel Mahon sold 861 shares at $531.97 for $458K on 2026-07-16
  • Total cluster value of $521K represents 0.0023% of UTHR's $22.7B market cap
  • Both insiders are C-suite, but the dollar amounts are immaterial

Financial Impact

Total sales of $521K — immaterial relative to $22.7B market cap

insider ownership

Risk Factors

  • CEO Rothblatt's larger option-exercise-driven sales (from separate filings) could continue and eventually reach 0.1%+ of market cap
  • No material risk from this cluster alone

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
82% bullish (22 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-UTHR-1784790118420
91 reports for UTHR
Performance horizon
80% Hit rate 4 of 5 directional calls best @ T+60▲ +5.53%Feb 25, 2026
Filters
Rows
Reports for UTHR — sortable, filterable
TypeNow
Sep 15, 2026
17d ago
Insider Cluster
NEUTRAL ★ 2/10
$500.35 $497.31▼ −0.61%▼ −2.72%$573.51 (+14.62%)
Sep 11, 2026
21d ago
Insider Cluster
NEUTRAL ★ 3/10
$497.11 $494.63▼ −0.50%▼ −0.28%$573.51 (+15.37%)
Sep 10, 2026
22d ago
Insider Cluster
MIXED ★ 4/10
$503.86 $497.27▼ −1.31%▼ −0.81%$573.51 (+13.82%)
Sep 9, 2026
23d ago
Insider Cluster
NEUTRAL ★ 3/10
$506.82 $498.48▼ −1.65%▼ −0.99%$573.51 (+13.16%)
Sep 4, 2026
28d ago
Insider Cluster
NEUTRAL ★ 2/10
$487.61 $502.70▲ +3.09%▲ +4.30%$573.51 (+17.62%)
Sep 3, 2026
29d ago
Insider Cluster
NEUTRAL ★ 2/10
$488.16 $497.11▲ +1.83%▲ +2.98%$573.51 (+17.48%)
Aug 28, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$515.46 $487.61▼ −5.40%▼ −5.51%$573.51 (+11.26%)
Aug 27, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$527.91 $492.02▼ −6.80%▼ −6.03%$573.51 (+8.64%)
Aug 26, 2026
5w ago
Insider Cluster
NEUTRAL ★ 3/10
$516.68 $492.02▼ −4.77%▼ −4.65%$573.51 (+11.00%)
Aug 25, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$516.68 $492.02▼ −4.77%▼ −4.65%$573.51 (+11.00%)
Showing 10 of 91

US Market Status

Market Open — Closes in 6h 24m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jul 23, 2026